Masuoka K. Lorianne - 22 Jan 2024 Form 4 Insider Report for DiaMedica Therapeutics Inc. (DMAC)

Role: Chief Medical Officer
Signature: /s/ Amy E. Culbert, attorney-in-fact
Issuer symbol: DMAC
Transactions as of: 22 Jan 2024
Net transactions value: $0
Form type: 4
Filing time: 23 Jan 2024, 16:23:11 UTC
Previous filing: 03 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	DMAC	Voting Common Shares, no par value per share						0	22 Jan 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DMAC	Stock option (right to buy)	Award	$0	+285,000		$0.000000	285,000	22 Jan 2024	Common Shares	285,000	$2.79	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Vests with respect to 25% of the underlying common shares on January 22, 2025 and with respect to the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on April 1, 2025.